Inventor
XU XUESONG
CN35 patents
⚠️ This page may combine multiple inventors who share the name “XU XUESONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XW LAB INC
13 patentsUS10968202B2Apr 6, 2021
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
XW LAB INC38 citations98
US10941107B2Mar 9, 2021
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
XW LAB INC36 citations98
US10882832B2Jan 5, 2021
Bicyclic heteroaryl derivatives and preparation and uses thereof
XW LAB INC36 citations98
US10774031B2Sep 15, 2020
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
XW LAB INC57 citations98
US10730853B2Aug 4, 2020
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
XW LAB INC38 citations98
US10640451B2May 5, 2020
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
XW LAB INC52 citations98
US10640476B2May 5, 2020
Bicyclic heteroaryl derivatives and preparation and uses thereof
XW LAB INC36 citations98
US10618886B1Apr 14, 2020
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
XW LAB INC38 citations98
US10501401B2Dec 10, 2019
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
XW LAB INC60 citations98
US10457627B2Oct 29, 2019
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
XW LAB INC61 citations98
US10836714B2Nov 17, 2020
Ketamine derivatives and compositions thereof
XW LAB INC41 citations97
US10683262B2Jun 16, 2020
Ketamine derivatives and compositions thereof
XW LAB INC40 citations97
US11149006B2Oct 19, 2021
Compounds as neurokinin-1 receptor antagonists and uses thereof
XW LAB INC0 citations62
XWPHARMA LTD
7 patentsUS12209060B2Jan 28, 2025
Ketamine derivatives and compositions thereof
XWPHARMA LTD1 citations74
US11420955B2Aug 23, 2022
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
XWPHARMA LTD2 citations73
US11440874B2Sep 13, 2022
Ketamine derivatives and compositions thereof
XWPHARMA LTD1 citations72
US12172980B2Dec 24, 2024
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
XWPHARMA LTD0 citations62
US11905247B2Feb 20, 2024
Compounds as neurokinin-1 receptor antagonists and uses thereof
XWPHARMA LTD0 citations62
US11639337B2May 2, 2023
Bicyclic heteroaryl derivatives and preparation and uses thereof
XWPHARMA LTD0 citations62
US11401249B2Aug 2, 2022
Bicyclic heteroaryl derivatives and preparation and uses thereof
XWPHARMA LTD0 citations62